-
TFAH cites major problems with state pandemic planning
Shortages of hospital beds and nurses top the list; flu vaccination rates decline in thirteen states, as does public health spending; Trust for America’s Health offers recommendations for improved preparedness
-
-
Researchers locate anthrax's Achilles' heal
Bacteria a master at using siderophores to extract iron from human hosts; researchers identify stealth protein that ovecomes human defenses; discovery could lead to improved drugs and testing
-
-
Frost and Sullivan offers report on WMD detection market
Business is booming, particularly in the federal sector; some end users, however, are shying away from the sometimes unreliable technology; research firm suggests industry needs better PR
-
-
Taiwanese researchers use lasers to weigh viruses
Method could improve identification of deadly pathogens; scientists use ion trap to bombard virus particles with laser light; a chip measures resultant oscillation to determine mass; technique limited to 50 nanometers or larger
-
-
Green onion contamination fuels cry for industry regulation
Complaining that federal oversight is lacking, supermarkets hire their own inspectors and demand growers shape up; in response, growers suggest a marketing order would be appropriate until new rules are drafted
-
-
Synergetics to support Animal Health and Surveillance Management
Coloradan IT company wins a multi-year contract with USDA to “beef” up its livestock health monitoring system; software to undergo vigorous testing and overhaul; new forms for disease reporting
-
-
Aethlon Medical moves forward with Hemopurifier
System removes viral pathogens such as Marburg and smallpox from human circulation; company requests an investigational device exemption under Project BioShield; dengue-related tests to begin in India
-
-
CDC awards $11.4 million in contracts for avian flu diagnostics
Agency hopes for a rapid bedside test that can be used by untrained personnel; winners are Cepheid, IQuum, Meso Scale Diagnostics, and Nanogen; more money forthcoming for successful companies
-
-
Interpol proposes model anti-bioterror law
Agency hopes to encourage states to criminalize the development and transfer of deadly pathogens; many countries limit prosecution to actual use; investigatory restrictions a major problem for some
-
-
GreeneChip offers rapid diagnosis of 30,000 pathogens
Unlike systems that can only test blood samples, new technology can assay tissue, urine, and stool; from Marburg to urinary tract infections, Columbia University’s GreeneChip offers a fast and inexpensive testing regime
-
-
Llama blood to assist in detecting pathogens
Breakthrough effort at the Southwest Foundation for Biomedical Research manipulates antibodies that can survive high temperatures; single-chain molecules do not fold under heat; Marburg and ebola assays first on the agenda
-
-
UK asks scientists to serve as bioterror barometers
After a Guardian reporter buys smallpox DNA on-line, the British government asks the Royal Society and other scientific bodies to keep a close look-out for emerging threats
-
-
Colorado researchers produce a better chemical warfare suit
Conventional butyl rubber is blended with polymerizable liquid crystal; water transfer rates and permeability substantially improved, allowing for lighter and safer suits; other applications include filters for brine and contaminated water
-
-
Longwatch to participate in WaterSentinel
Company will install remote video alarm monitoring services; WaterSentinel a major push to secure nation’s water supplies; integration with SCADA protocol a major factor in winning such projects; company looks for installation and integration partners
-
-
Nations review the Biological and Toxin Weapons Convention
Sponored by the Green Cross, meeting in Geneva takes on biowarfare and natural disease outbreaks; concerns linger over nonsignatories; biotech seen as key line of defense
-
More headlines
The long view
Are We Ready for a ‘DeepSeek for Bioweapons’?
Anthropic’s Claude 4 is a warning sign: AI that can help build bioweapons is coming, and could be widely available soon. Steven Adler writes that we need to be prepared for the consequences: “like a freely downloadable ‘DeepSeek for bioweapons,’ available across the internet, loadable to the computer of any amateur scientist who wishes to cause mass harm. With Anthropic’s Claude Opus 4 having finally triggered this level of safety risk, the clock is now ticking.”
A Brief History of Federal Funding for Basic Science
Biomedical science in the United States is at a crossroads. For 75 years, the federal government has partnered with academic institutions, fueling discoveries that have transformed medicine and saved lives. Recent moves by the Trump administration — including funding cuts and proposed changes to how research support is allocated — now threaten this legacy.
Vaccine Integrity Project Says New FDA Rules on COVID-19 Vaccines Show Lack of Consensus, Clarity
Sidestepping both the FDA’s own Vaccines and Related Biological Products Advisory Committee and the CDC’s Advisory Committee on Immunization Practices (ACIP), two Trump-appointed FDA leaders penned an opinion piece in the New England Journal of Medicine to announce new, more restrictive, COVID-19 vaccine recommendations. Critics say that not seeking broad input into the new policy, which would help FDA to understand its implications, feasibility, and the potential for unintended consequences, amounts to policy by proclamation.